embryonal rhabdomyosarcoma
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
A recurrent neomorphic mutation in <span class="gene" id="24793135-0-35-40">MYOD1</span> defines a clinically aggressive subset of <span class="disease" id="24793135-0-83-109">embryonal rhabdomyosarcoma</span> associated with PI3K-AKT pathway mutations.